288 related articles for article (PubMed ID: 30506719)
1. Clinical significance of long noncoding RNA VIM-AS1 and CTBP1-AS2 expression in type 2 diabetes.
Erfanian Omidvar M; Ghaedi H; Kazerouni F; Kalbasi S; Shanaki M; Miraalamy G; Zare A; Rahimipour A
J Cell Biochem; 2019 Jun; 120(6):9315-9323. PubMed ID: 30506719
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LY86-AS1 and HCG27_201 expression in type 2 diabetes mellitus.
Saeidi L; Ghaedi H; Sadatamini M; Vahabpour R; Rahimipour A; Shanaki M; Mansoori Z; Kazerouni F
Mol Biol Rep; 2018 Dec; 45(6):2601-2608. PubMed ID: 30328000
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of long noncoding RNA SNHG17 and TTC28-AS1 is associated with type 2 diabetes mellitus.
Mohamadi M; Ghaedi H; Kazerouni F; Erfanian Omidvar M; Kalbasi S; Shanaki M; Miraalamy G; Rahimipour A
Scand J Clin Lab Invest; 2019 Nov; 79(7):519-523. PubMed ID: 31509021
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA VIM Antisense RNA 1 (VIM-AS1) sponges microRNA-29 to participate in diabetic retinopathy.
Zeng F; Luo G; Lu Y; Zhang Z; Zhou Y; Chen Y; Zhou Z
Acta Diabetol; 2020 Sep; 57(9):1111-1116. PubMed ID: 32447557
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CTBP1-AS2 alleviates high glucose-induced oxidative stress, ECM accumulation, and inflammation in diabetic nephropathy via miR-155-5p/FOXO1 axis.
Wang G; Wu B; Zhang B; Wang K; Wang H
Biochem Biophys Res Commun; 2020 Nov; 532(2):308-314. PubMed ID: 32868076
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of vimentin and the related lncRNA network in breast cancer.
Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CTBP1-AS2 is upregulated in osteoarthritis and increases the methylation of miR-130a gene to inhibit chondrocyte proliferation.
Zhang H; Li J; Shao W; Shen N
Clin Rheumatol; 2020 Nov; 39(11):3473-3478. PubMed ID: 32388751
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary study on the diagnostic value of serum-derived exosomal lncRNA in epithelial ovarian cancer].
Li YW; Li L
Zhonghua Fu Chan Ke Za Zhi; 2022 Mar; 57(3):198-209. PubMed ID: 35385957
[No Abstract] [Full Text] [Related]
9. KCNQ1OT1, HIF1A-AS2 and APOA1-AS are promising novel biomarkers for diagnosis of coronary artery disease.
Zhang Y; Zhang L; Wang Y; Ding H; Xue S; Yu H; Hu L; Qi H; Wang Y; Zhu W; Liu D; Li P
Clin Exp Pharmacol Physiol; 2019 Jul; 46(7):635-642. PubMed ID: 30941792
[TBL] [Abstract][Full Text] [Related]
10. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: Differential expression profile of circulating lncRNA
.
Yang Y; Lv X; Fan Q; Wang X; Xu L; Lu X; Chen T
Clin Nephrol; 2019 Jul; 92(1):25-35. PubMed ID: 31079598
[TBL] [Abstract][Full Text] [Related]
11. LncRNA CTBP1-AS2 regulates miR-216a/ PTEN to suppress ovarian cancer cell proliferation.
Cui K; Zhu G
J Ovarian Res; 2020 Jul; 13(1):84. PubMed ID: 32711584
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of CHL1 gene and long non-coding RNA CHL1-AS1, CHL1-AS2 in ovarian endometriosis.
Zhang C; Wu W; Ye X; Ma R; Luo J; Zhu H; Chang X
Eur J Obstet Gynecol Reprod Biol; 2019 May; 236():177-182. PubMed ID: 30943448
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
14. Association between lncRNAs in plasma exosomes and diabetic retinopathy.
Ye Q; Li L; Shao Z; Xu M; Li L; Yan Q; Huang B; Zhao T
Front Endocrinol (Lausanne); 2022; 13():987488. PubMed ID: 36187126
[TBL] [Abstract][Full Text] [Related]
15. Sp1-induced LncRNA CTBP1-AS2 is a novel regulator in cardiomyocyte hypertrophy by interacting with FUS to stabilize TLR4.
Luo X; He S; Hu Y; Liu J; Chen X
Cardiovasc Pathol; 2019; 42():21-29. PubMed ID: 31220774
[TBL] [Abstract][Full Text] [Related]
16. Serum LncRNA-ATB and FAM83H-AS1 as diagnostic/prognostic non-invasive biomarkers for breast cancer.
El-Ashmawy NE; Hussien FZ; El-Feky OA; Hamouda SM; Al-Ashmawy GM
Life Sci; 2020 Oct; 259():118193. PubMed ID: 32763293
[TBL] [Abstract][Full Text] [Related]
17. High level of lncRNA NR2F1-AS1 predict the onset and progression of diabetic retinopathy in type 2 diabetes.
Ji X; Sun J; Wang Z
Exp Eye Res; 2022 Jun; 219():109069. PubMed ID: 35398206
[TBL] [Abstract][Full Text] [Related]
18. Circulating LncRNAs Analysis in Patients with Type 2 Diabetes Reveals Novel Genes Influencing Glucose Metabolism and Islet β-Cell Function.
Ruan Y; Lin N; Ma Q; Chen R; Zhang Z; Wen W; Chen H; Sun J
Cell Physiol Biochem; 2018; 46(1):335-350. PubMed ID: 29590649
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNA VIM Antisense RNA 1 (VIM-AS1) Plays an Important Role in Development of Preeclampsia by Regulation of Epithelial Mesenchymal Transition.
Zhao X; Jiang X; Liu Z; Zhou M; Zhang J; Wang X; Li X
Med Sci Monit; 2019 Nov; 25():8306-8314. PubMed ID: 31685789
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA VIM-AS1 promotes colorectal cancer progression and metastasis by inducing EMT.
Rezanejad Bardaji H; Asadi MH; Yaghoobi MM
Eur J Cell Biol; 2018 May; 97(4):279-288. PubMed ID: 29656793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
